To compare the success rate of Stop GnRH agonist-antagonist protocol with conventional IVF protocols
Phase 4
- Conditions
- Health Condition 1: N978- Female infertility of other origin
- Registration Number
- CTRI/2023/10/058780
- Lead Sponsor
- All India Institute of Medical Sciences, New Delhi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
22 to 40 years of age
Unexplained infertility
Tubal factor
Mild/moderate male factor infertility
Exclusion Criteria
•Polycystic ovary syndrome (PCOS)
•Endometriosis
•Fibroid or adenomyoma distorting the endometrial cavity
•Severe male factor infertility
•Previous two or more failed IVF/ICSI cycles
•Patients who do not give written informed consent to participate
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method umber of oocytes retrieved <br/ ><br> <br/ ><br>Timepoint: 2 weeks <br/ ><br> <br/ ><br>
- Secondary Outcome Measures
Name Time Method Cleavage rateTimepoint: 2 weeks;Clinical pregnancy rate per embryo transferTimepoint: 7 weeks;Cumulative clinical pregnancy rate <br/ ><br>Cumulative live birth rate (CLBR) <br/ ><br>Timepoint: 37 weeks;Cycle cancellation rateTimepoint: 2 weeks;Fertilization rateTimepoint: 2 weeks;Total dose of gonadotrophins required <br/ ><br>Duration of controlled ovarian stimulation <br/ ><br>Peak serum estradiol (E2) & progesterone (P4) on the day of trigger <br/ ><br>FORT/Follicular output rate <br/ ><br>Number of mature oocytes(MII) retrieved Timepoint: 2 weeks